An Observational Study to Learn More About the Use of Darolutamide as a Part of a Combination Therapy in Belgian Men With Metastatic Hormone-Sensitive Prostate Cancer in Routine Medical Care
Clinical trial NCT06498921 · COMPLETED
Trial details
- NCT number
- NCT06498921
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-07-15
- Primary completion
- 2024-09-15
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.